TY - JOUR
T1 - Design Strategies and Applications of Circulating Cell-Mediated Drug Delivery Systems
AU - Su, Yixue
AU - Xie, Zhiwei
AU - Kim, Gloria B.
AU - Dong, Cheng
AU - Yang, Jian
N1 - Publisher Copyright:
© 2015 American Chemical Society.
PY - 2015/12/14
Y1 - 2015/12/14
N2 - Drug delivery systems, particularly nanomaterial-based drug delivery systems, possess a tremendous amount of potential to improve the diagnostic and therapeutic effects of drugs. Controlled drug delivery targeted to a specific disease is designed to significantly improve the pharmaceutical effects of drugs and reduce their side effects. Unfortunately, only a few targeted drug delivery systems can achieve high targeting efficiency after intravenous injection, even with the development of numerous surface markers and targeting modalities. Thus, alternative drug and nanomedicine targeting approaches are desired. Circulating cells, such as erythrocytes, leukocytes, and stem cells, present innate disease sensing and homing properties. Hence, using living cells as drug delivery carriers has gained increasing interest in recent years. This review highlights the recent advances in the design of cell-mediated drug delivery systems and targeting mechanisms. The approaches of drug encapsulation/conjugation to cell carriers, cell-mediated targeting mechanisms, and the methods of controlled drug release are elaborated here. Cell-based "live" targeting and delivery could be used to facilitate a more specific, robust, and smart payload distribution for the next-generation drug delivery systems.
AB - Drug delivery systems, particularly nanomaterial-based drug delivery systems, possess a tremendous amount of potential to improve the diagnostic and therapeutic effects of drugs. Controlled drug delivery targeted to a specific disease is designed to significantly improve the pharmaceutical effects of drugs and reduce their side effects. Unfortunately, only a few targeted drug delivery systems can achieve high targeting efficiency after intravenous injection, even with the development of numerous surface markers and targeting modalities. Thus, alternative drug and nanomedicine targeting approaches are desired. Circulating cells, such as erythrocytes, leukocytes, and stem cells, present innate disease sensing and homing properties. Hence, using living cells as drug delivery carriers has gained increasing interest in recent years. This review highlights the recent advances in the design of cell-mediated drug delivery systems and targeting mechanisms. The approaches of drug encapsulation/conjugation to cell carriers, cell-mediated targeting mechanisms, and the methods of controlled drug release are elaborated here. Cell-based "live" targeting and delivery could be used to facilitate a more specific, robust, and smart payload distribution for the next-generation drug delivery systems.
UR - http://www.scopus.com/inward/record.url?scp=84969247688&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84969247688&partnerID=8YFLogxK
U2 - 10.1021/ab500179h
DO - 10.1021/ab500179h
M3 - Review article
C2 - 25984572
AN - SCOPUS:84969247688
SN - 2373-9878
VL - 1
SP - 201
EP - 217
JO - ACS Biomaterials Science and Engineering
JF - ACS Biomaterials Science and Engineering
IS - 4
ER -